Sanzida Haque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sanzida Haque has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Chengyue Li
Department of Biomedical Engineering, Illinois Institute of Technology, 3255 S Dearborn St, Chicago IL 60616, USA
1 shared publication- Cody C. Rounds
Department of Biomedical Engineering, Oregon Health and Science University (OHSU), Portland OR 97239, USA
1 shared publication Devin Nissen
Department of Biology, Illinois Institute of Technology, 3101 S Dearborn St, Chicago IL 60616, USA
1 shared publication- Dhruv Ranjan
Department of Biomedical Engineering, Northwestern University, Chicago IL 60611, USA
1 shared publication - Kenneth M. Tichauer
Lawson Research Institute, St. Joseph’s Health Care London, London, ON, Canada
1 shared publication - Marcella K. Vaicik
Department of Biomedical Engineering, Illinois Institute of Technology, 3255 S Dearborn St, Chicago IL 60616, USA
1 shared publication
Latest Publications
- Open Access
Synchrotron diffraction reveals distinct collagen-associated distributions of EGFR-targeted antibody and affibody in pancreatic tumors
Tumor extracellular matrix may influence the distribution of targeted agents differently across molecular formats. We compared how an antibody and an affibody targeting the same receptor distribute relative to collagen-associated tissue structure in pancreatic tumors. Methods: Cetuximab-IRDye700DX, an epidermal growth factor receptor (EGFR)-targeted fluorescent antibody, and ABY-029, an EGFR-targeted fluorescent affibody, were co-administered intravenously to 12 athymic nude mice bearing orthotopic pancreatic tumors: eight AsPC-1 and four PANC-1. Tumors were harvested at 3 or 24 h after injection, with four AsPC-1 and two PANC-1 mice at each time. Fluorescence images from 21 tissue slices were registered to scanning synchrotron X-ray diffraction (XRD) maps to compare each agent’s distribution with local collagen-associated diffraction intensity. Results: Cetuximab–XRD correlations were negative in all 12 mice at every evaluated binning scale (100–400 µm; all adjusted P = 0.0039). Cohort-average correlations were more negative for cetuximab than ABY-029 at all four scales (paired adjusted P = 0.0137–0.0381). At 400 µm, mean correlations were −0.502 and −0.249, respectively. ABY-029 correlations did not differ significantly from zero after adjustment. Vehicle controls showed positive background fluorescence–XRD associations. Conclusions: Cetuximab exhibited consistent inverse spatial associations with collagen-associated diffraction and stronger cohort-average associations than ABY-029. These findings show that agents targeting the same receptor can differ in their relationships with local tissue structure and support spatially resolved assessment of tissue access when selecting molecular formats for imaging and therapy.
Open AccessSynchrotron diffraction reveals distinct collagen-associated distributions of EGFR-targeted antibody and affibody in pancreatic tumors
Tumor extracellular matrix may influence the distribution of targeted agents differently across molecular formats. We compared how an antibody and an affibody targeting the same receptor distribute relative to collagen-associated tissue structure in pancreatic tumors. Methods: Cetuximab-IRDye700DX, an epidermal growth factor receptor (EGFR)-targeted fluorescent antibody, and ABY-029, an EGFR-targeted fluorescent affibody, were co-administered intravenously to 12 athymic nude mice bearing orthotopic pancreatic tumors: eight AsPC-1 and four PANC-1. Tumors were harvested at 3 or 24 h after injection, with four AsPC-1 and two PANC-1 mice at each time. Fluorescence images from 21 tissue slices were registered to scanning synchrotron X-ray diffraction (XRD) maps to compare each agent’s distribution with local collagen-associated diffraction intensity. Results: Cetuximab–XRD correlations were negative in all 12 mice at every evaluated binning scale (100–400 µm; all adjusted P = 0.0039). Cohort-average correlations were more negative for cetuximab than ABY-029 at all four scales (paired adjusted P = 0.0137–0.0381). At 400 µm, mean correlations were −0.502 and −0.249, respectively. ABY-029 correlations did not differ significantly from zero after adjustment. Vehicle controls showed positive background fluorescence–XRD associations. Conclusions: Cetuximab exhibited consistent inverse spatial associations with collagen-associated diffraction and stronger cohort-average associations than ABY-029. These findings show that agents targeting the same receptor can differ in their relationships with local tissue structure and support spatially resolved assessment of tissue access when selecting molecular formats for imaging and therapy.